Omnicell (OMCL) Financials

Omnicell Inc (OMCL) is a leading provider of medication management and supply chain solutions for healthcare facilities. With a focus on improving patient safety and operational efficiency, Omnicell offers a comprehensive suite of products and services designed to streamline medication workflows and ensure the secure and accurate delivery of medications. The company's financials reflect its strong performance and growth in recent years. As of the latest reporting period, Omnicell's total revenue was $1.1 billion, with gross profit of $532 million. The company's operating cash flow was $119 million, while its free cash flow was $88 million. In terms of profitability, Omnicell recorded a net income of $62 million. The company's balance sheet indicates a healthy financial position, with total assets of $1.7 billion and total liabilities of $622 million. Omnicell's stockholders' equity is reported at $1.1 billion. The company has a minimal cash equivalent balance of $15 million. Additionally, Omnicell has managed its debt well, with a net debt position of $336 million. Overall, Omnicell's financials demonstrate its ability to generate strong revenues, maintain profitability, and manage its financial obligations efficiently.

Looking specifically at Omnicell's operating performance, the company's EBIT stands at $90 million, while its EBITDA is $124 million. These figures indicate that Omnicell has been able to generate a healthy level of earnings before interest and taxes, as well as earnings before interest, taxes, depreciation, and amortization. This reflects the company's ability to effectively manage its operating expenses and generate profits from its core operations. By focusing on innovation and providing value-added solutions to healthcare providers, Omnicell has positioned itself as a leader in the medication management industry. With its strong financials and commitment to improving patient care, Omnicell is well-positioned for continued success in the future.